Consecutive intrabronchial administration of Wharton’s jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)

Direct intrabronchial administration of MSC in a patient on ECMO is feasible and safe, and may be a new avenue to be assayed in ECMO patients with inflammatory, immunological and infectious diseases of the lung.

Authors

Institutions

Publication Details

Journal
Stem Cell Research & Therapy
Published
2025-04-05
DOI
https://doi.org/10.1186/s13287-025-04289-3
Citations
3
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
4.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Consecutive intrabronchial administration of Wharton’s jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)

Olga Serrano Garrote, Olga Ordóñez, Sergi Querol, Aitor Gonzaga et al.
3 citations
Stem Cell Research & Therapy
Mesenchymal stem cell research
4.88
article

Consecutive intrabronchial administration of Wharton’s jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)

Olga Serrano Garrote, Olga Ordóñez, Sergi Querol, Aitor Gonzaga, Bernat Soria, Eduardo Fernández, Cristina Prat‐Vidal, A Castro Frontiñán, Luis Blasco, Etelvina Andreu, Sylvia Belda Hofheinz, Rodrigo Íñiguez, Gema Martı́nez, Rocío Morante Valverde, María Salomé Albi Rodríguez, Ana M. Gutiérrez‐Vílchez, Luis Ignacio González‐Granado, Nerea Domínguez‐Pinilla, Nerea Castillo‐Flores, María López Díaz, Álvaro Gimeno Díaz de Atauri, Margarita Blanco, Cupuerán Yánez, E. López, Marga Anton-Bonete, Clara Aymerich, Xabier Freire
article en
3 citations

Abstract

Direct intrabronchial administration of MSC in a patient on ECMO is feasible and safe, and may be a new avenue to be assayed in ECMO patients with inflammatory, immunological and infectious diseases of the lung.

Stem Cell Research & TherapyVol. 16(1)
Universitat de Miguel Hernández d'Elx (ES), Research Institute Hospital 12 de Octubre (ES), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Banc de Sang i Teixits (ES)
Generalitat Valenciana, Agencia Española de Medicamentos y Productos Sanitarios, Université Toulouse III - Paul Sabatier, Instituto de Salud Carlos III
Zero hunger
Openalex Percentile: Top 6%
Mesenchymal stem cell research
4.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.